251 related articles for article (PubMed ID: 34548400)
1. Design of proteasome inhibitors with oral efficacy in vivo against
Xie SC; Metcalfe RD; Mizutani H; Puhalovich T; Hanssen E; Morton CJ; Du Y; Dogovski C; Huang SC; Ciavarri J; Hales P; Griffin RJ; Cohen LH; Chuang BC; Wittlin S; Deni I; Yeo T; Ward KE; Barry DC; Liu B; Gillett DL; Crespo-Fernandez BF; Ottilie S; Mittal N; Churchyard A; Ferguson D; Aguiar ACC; Guido RVC; Baum J; Hanson KK; Winzeler EA; Gamo FJ; Fidock DA; Baud D; Parker MW; Brand S; Dick LR; Griffin MDW; Gould AE; Tilley L
Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34548400
[TBL] [Abstract][Full Text] [Related]
2. Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized Mice.
Zhan W; Zhang H; Ginn J; Leung A; Liu YJ; Michino M; Toita A; Okamoto R; Wong TT; Imaeda T; Hara R; Yukawa T; Chelebieva S; Tumwebaze PK; Lafuente-Monasterio MJ; Martinez-Martinez MS; Vendome J; Beuming T; Sato K; Aso K; Rosenthal PJ; Cooper RA; Meinke PT; Nathan CF; Kirkman LA; Lin G
Angew Chem Int Ed Engl; 2021 Apr; 60(17):9279-9283. PubMed ID: 33433953
[TBL] [Abstract][Full Text] [Related]
3. Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitors.
Hsu HC; Li D; Zhan W; Ye J; Liu YJ; Leung A; Qin J; Crespo B; Gamo FJ; Zhang H; Cui L; Roth A; Kirkman LA; Li H; Lin G
Nat Commun; 2023 Dec; 14(1):8302. PubMed ID: 38097652
[TBL] [Abstract][Full Text] [Related]
4. Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome.
Xie SC; Gillett DL; Spillman NJ; Tsu C; Luth MR; Ottilie S; Duffy S; Gould AE; Hales P; Seager BA; Charron CL; Bruzzese F; Yang X; Zhao X; Huang SC; Hutton CA; Burrows JN; Winzeler EA; Avery VM; Dick LR; Tilley L
J Med Chem; 2018 Nov; 61(22):10053-10066. PubMed ID: 30373366
[TBL] [Abstract][Full Text] [Related]
5. The cryo-EM structure of the Plasmodium falciparum 20S proteasome and its use in the fight against malaria.
Li H; Bogyo M; da Fonseca PC
FEBS J; 2016 Dec; 283(23):4238-4243. PubMed ID: 27286897
[TBL] [Abstract][Full Text] [Related]
6. Structure- and function-based design of Plasmodium-selective proteasome inhibitors.
Li H; O'Donoghue AJ; van der Linden WA; Xie SC; Yoo E; Foe IT; Tilley L; Craik CS; da Fonseca PC; Bogyo M
Nature; 2016 Feb; 530(7589):233-6. PubMed ID: 26863983
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance.
Kirkman LA; Zhan W; Visone J; Dziedziech A; Singh PK; Fan H; Tong X; Bruzual I; Hara R; Kawasaki M; Imaeda T; Okamoto R; Sato K; Michino M; Alvaro EF; Guiang LF; Sanz L; Mota DJ; Govindasamy K; Wang R; Ling Y; Tumwebaze PK; Sukenick G; Shi L; Vendome J; Bhanot P; Rosenthal PJ; Aso K; Foley MA; Cooper RA; Kafsack B; Doggett JS; Nathan CF; Lin G
Proc Natl Acad Sci U S A; 2018 Jul; 115(29):E6863-E6870. PubMed ID: 29967165
[TBL] [Abstract][Full Text] [Related]
8. Support vector machine based prediction of P. falciparum proteasome inhibitors and development of focused library by molecular docking.
Subramaniam S; Mehrotra M; Gupta D
Comb Chem High Throughput Screen; 2011 Dec; 14(10):898-907. PubMed ID: 21843142
[TBL] [Abstract][Full Text] [Related]
9. High-resolution cryo-EM proteasome structures in drug development.
Morris EP; da Fonseca PCA
Acta Crystallogr D Struct Biol; 2017 Jun; 73(Pt 6):522-533. PubMed ID: 28580914
[TBL] [Abstract][Full Text] [Related]
10. Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome Inhibitors.
Garg S; Kreutzfeld O; Chelebieva S; Tumwebaze PK; Byaruhanga O; Okitwi M; Orena S; Katairo T; Nsobya SL; Conrad MD; Aydemir O; Legac J; Gould AE; Bayles BR; Bailey JA; Duffey M; Lin G; Kirkman LA; Cooper RA; Rosenthal PJ
Antimicrob Agents Chemother; 2022 Oct; 66(10):e0081722. PubMed ID: 36094216
[TBL] [Abstract][Full Text] [Related]
11. Improvement of Asparagine Ethylenediamines as Anti-malarial
Zhan W; Visone J; Ouellette T; Harris JC; Wang R; Zhang H; Singh PK; Ginn J; Sukenick G; Wong TT; Okoro JI; Scales RM; Tumwebaze PK; Rosenthal PJ; Kafsack BFC; Cooper RA; Meinke PT; Kirkman LA; Lin G
J Med Chem; 2019 Jul; 62(13):6137-6145. PubMed ID: 31177777
[TBL] [Abstract][Full Text] [Related]
12. Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents.
Stokes BH; Yoo E; Murithi JM; Luth MR; Afanasyev P; da Fonseca PCA; Winzeler EA; Ng CL; Bogyo M; Fidock DA
PLoS Pathog; 2019 Jun; 15(6):e1007722. PubMed ID: 31170268
[TBL] [Abstract][Full Text] [Related]
13. Identification of potent and selective non-covalent inhibitors of the Plasmodium falciparum proteasome.
Li H; Tsu C; Blackburn C; Li G; Hales P; Dick L; Bogyo M
J Am Chem Soc; 2014 Oct; 136(39):13562-5. PubMed ID: 25226494
[TBL] [Abstract][Full Text] [Related]
14. Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome.
Deni I; Stokes BH; Ward KE; Fairhurst KJ; Pasaje CFA; Yeo T; Akbar S; Park H; Muir R; Bick DS; Zhan W; Zhang H; Liu YJ; Ng CL; Kirkman LA; Almaliti J; Gould AE; Duffey M; O'Donoghue AJ; Uhlemann AC; Niles JC; da Fonseca PCA; Gerwick WH; Lin G; Bogyo M; Fidock DA
Cell Chem Biol; 2023 May; 30(5):470-485.e6. PubMed ID: 36963402
[TBL] [Abstract][Full Text] [Related]
15. Development of Potent and Highly Selective Epoxyketone-Based Plasmodium Proteasome Inhibitors.
Almaliti J; Fajtová P; Calla J; LaMonte GM; Feng M; Rocamora F; Ottilie S; Glukhov E; Boura E; Suhandynata RT; Momper JD; Gilson MK; Winzeler EA; Gerwick WH; O'Donoghue AJ
Chemistry; 2023 Apr; 29(20):e202203958. PubMed ID: 36617500
[TBL] [Abstract][Full Text] [Related]
16. The proteasome as a target to combat malaria: hits and misses.
Krishnan KM; Williamson KC
Transl Res; 2018 Aug; 198():40-47. PubMed ID: 30009761
[TBL] [Abstract][Full Text] [Related]
17. Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model.
Booker ML; Bastos CM; Kramer ML; Barker RH; Skerlj R; Sidhu AB; Deng X; Celatka C; Cortese JF; Guerrero Bravo JE; Crespo Llado KN; Serrano AE; Angulo-Barturen I; Jiménez-Díaz MB; Viera S; Garuti H; Wittlin S; Papastogiannidis P; Lin JW; Janse CJ; Khan SM; Duraisingh M; Coleman B; Goldsmith EJ; Phillips MA; Munoz B; Wirth DF; Klinger JD; Wiegand R; Sybertz E
J Biol Chem; 2010 Oct; 285(43):33054-33064. PubMed ID: 20702404
[TBL] [Abstract][Full Text] [Related]
18. The structure of the PA28-20S proteasome complex from Plasmodium falciparum and implications for proteostasis.
Xie SC; Metcalfe RD; Hanssen E; Yang T; Gillett DL; Leis AP; Morton CJ; Kuiper MJ; Parker MW; Spillman NJ; Wong W; Tsu C; Dick LR; Griffin MDW; Tilley L
Nat Microbiol; 2019 Nov; 4(11):1990-2000. PubMed ID: 31384003
[TBL] [Abstract][Full Text] [Related]
19. Structure-Activity Relationship Studies of Antimalarial
Zhang H; Ginn J; Zhan W; Leung A; Liu YJ; Toita A; Okamoto R; Wong TT; Imaeda T; Hara R; Michino M; Yukawa T; Chelebieva S; Tumwebaze PK; Vendome J; Beuming T; Sato K; Aso K; Rosenthal PJ; Cooper RA; Liverton N; Foley M; Meinke PT; Nathan CF; Kirkman LA; Lin G
J Med Chem; 2023 Jan; 66(2):1484-1508. PubMed ID: 36630286
[TBL] [Abstract][Full Text] [Related]
20. Development of peptidomimetic boronates as proteasome inhibitors.
Micale N; Ettari R; Lavecchia A; Di Giovanni C; Scarbaci K; Troiano V; Grasso S; Novellino E; Schirmeister T; Zappalà M
Eur J Med Chem; 2013 Jun; 64():23-34. PubMed ID: 23639651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
